Regeneus Ltd Stock Market Press Releases and Company Profile
CEO John Martin's Presentation at the Alliance of Regenerative Medicine (ARM) Investor Day 2015
CEO John Martin's Presentation at the Alliance of Regenerative Medicine (ARM) Investor Day 2015

Sydney, April 14, 2015 AEST (ABN Newswire) - Organised by the Alliance for Regenerative Medicine (ARM), the 3rd Annual Regenerative Medicine Investor Day was held on March 25th 2015 in New York City.

The one-day investor conference focused exclusively on the regenerative medicine and advanced therapies sector. Regeneus Ltd (googlechartASX:RGS) was one of more than 30 companies that presented during the course of the day.

Below is Regeneus CEO John Martin's presentation to the group, courtesy of the Alliance for Regenerative Medicine (ARM).

To view the video presentation in New York, please visit:
http://www.youtube.com/watch?t=54&v=WGsvzHNEZQA


About Regeneus Ltd

Regeneus Ltd ASX:RGSRegeneus Ltd (ASX:RGS) is a Sydney-based clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies. The regenerative therapies seek to address unmet medical needs in human health markets, focusing on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza(TM) and Sygenus. Visit www.regeneus.com.au for more information.

https://plus.google.com/108721050557390681250 https://twitter.com/Regeneus https://www.facebook.com/pages/Regeneus/110433905646491 https://www.youtube.com/user/Regeneus http://www.linkedin.com/company/regeneus-ltd?trk=top_nav_home abnnewswire.com 


Contact

Regeneus Ltd
T: +61-2-9499-8010
F: +61-2-9499-8020
E: info@regeneus.com.au
WWW: www.regeneus.com.au


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 8) (Last 30 Days: 18) (Since Published: 5199)